Baird analyst Colleen Kusy lowered the firm’s price target on Apellis to $70 from $115 and keeps an Outperform rating on the shares. The firm said its blowout Syfovre quarter is rightfully overshadowed by ongoing safety concerns. While Baird expects uncertainty to weigh on the stock in the near term, we think the stock could reverse course.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on APLS: